Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 04, 2017

Ixchel Pharma, LLC. v. Biogen Inc.

Track this case

Case Number:

2:17-cv-00715

Court:

California Eastern

Nature of Suit:

Anti-Trust

Judge:

William B. Shubb

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 26, 2018

    Ixchel On Last Legs With Antitrust Claims Against Biogen

    A California federal judge on Thursday gave Ixchel Pharma LLC one last chance to accuse Biogen Inc. of entering into an anti-competitive agreement with another company and undermining Ixchel's development of a treatment for a rare neuromuscular disease, holding the latest complaint is just as deficient as its predecessor.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login